A study on sarcoidosis with clinical profile, diagnosis and treatment

A clinic’s perspective

https://doi.org/10.53730/ijhs.v6nS9.12968

Authors

  • K. Venksteswararao Associate Professor, Department of Pulmonary Medicine, GITAM Institute of Medical Sciences and Research (GIMSR), GITAM Deemed to be University, Visakhapatnam-530045, Andhra Pradesh, India.
  • T. Raviraju Professor of Nephrology and Honorary adviser, GITAM Institute of Medical Sciences and Research (GIMSR), GITAM Deemed to be University, Visakhapatnam-530045, Andhra Pradesh, India.
  • Syam Kumar Addepalli Associate Professor, Department of Pharmacology, GITAM Institute of Medical sciences and Research (GIMSR), GITAM Deemed to be University, Visakhapatnam-530045, Andhra Pradesh, India.

Keywords:

Sarcoidosis, Granuloma, Mediastinal adenopathy, Micronodules on HRCT, Multi system disease

Abstract

Background: Sarcoidosis is a multisystem granulomatous disease of unknown etiology and a close mimic of Tuberculosis in TB endemic are as which poses a diagnostic challenge. Objective: The main objective of the study is to determine the prevalence of Sarcoidosis with respect to its clinical profile, diagnosis and treatment. Methodology: The present study is a descriptive study with20 documented cases of Sarcoidosis from South India; the study span was from 2011 to 2021with Particular reference to cardiac and other organ involvement. Results: The results showed pulmonary involvement in 100% of patients followed by peripheral Lymph nodal involvement in 70% of patients which offered easy and cost effective diagnosis .Cardiac involvement was noted in 15% of patients as against scarce case reports from India. Ocular and Cutaneous involvement was seen in 15% of patients each. Kidneys and Parotids were involved in 5% of Patients. It should be suspected in any patient with appropriate clinical/radiological findings and the diagnosis of non-caseating granuloma should be made from an easily accessible peripheral site, followed by bronchoscopic and other methods. It should be differentiated from Tuberculosis and other granulomatous lesions. It is a steroid responsive condition and carries good prognosis.

Downloads

Download data is not yet available.

References

Arkema EV ,Grunevald J. Sarcoidosis incidence and prevalence , a nationwide register- based assessment in Sweden. EURResp2016;48(6):1690-1699.

Baughman RP, Field S. Sarcoidosis in America: analysis based on health care use. Ann Aam Thoracic soc 2016;13(8):244-1252.

BaughmanRP,Tierstein et al. A case control etiologic study of Sarcoidosis(ACCESS)Research group: clinicalcharacteristics of patients in a case control study of sarcoidosis Am J JRespi. Criti.Med2001;164(10,pt 1)1885-1889.

Caliskan C, Prasse A. Treating Sarcoidosis and potential new drugs. ERS Monograph.2022:328-336.

David Birnie,Andrew C.T; Cardiac Sarcoidosis , Clinics in Chest Medicine,Dec 2015 ,vol 36,pg 657-668.

HamzehNY ,Weinberger HD ,Management of cardiac sarcoidosis in the united states, a Delphi study. Chest 2012;141(1),154-162.

Karan M, PB Sryma PB. Clinical Profile of 327 patients with Sarcoidosis in India: An Ambispective Cohort Study in a Tuberculosis (TB) endemic population. Lung India2022;39:51-7.

KassirerJP.Our stubborn quest for diagnostic certainty.A cause of excessive testing.N Engl J Med 1989; 320:1489-91.

Nagai S ,Yokomatsuet al Treatment with low dose corticosteroid and Methotrexate in Sarcoidosis patients with cardiac lesions. Inter med 2014;53(5)427-433.

Pasadhika S Rosenbaum JT .Ocularsarcoidosiscliche med 2015;36(4);669-683..

PatompongUngprasert Jay H, Matteson et al. Clinical Manifestations, Diagnosis,and Treatment of Sarcoidosis,Mayo cli proc inn qual 2019;3(3)358-375.

Raj Kumar. Sarcoidosis North Indian Population : a retrospective study, V P Chest Institute, Chest Dis Allied Sci 2012;54-99-104.

Remy-Jardin M. Pulmonary sarcoidosis :role of CT in the evaluation of Disease activity and functional impairment and in prognosis assessment..Radiology 1994;191(3):675-80.

Talwar D, IyerH . Pulmonary Sarcoidosis. Indian J Rheumatol 2021;16:S47-57

Ungprasert P, Carmona EM. Epidemiology of Sarcoidosis 1946 –2013 ; a population based study. MayoCln proc 2016; 91(2):183-188

Valeyre D. ERS Clinical practice guidelines on treatment of sarcoidosis. Eur.Res J. 2021;58:2004079.

Published

24-09-2022

How to Cite

Venksteswararao, K., Raviraju, T., & Addepalli, S. K. (2022). A study on sarcoidosis with clinical profile, diagnosis and treatment: A clinic’s perspective. International Journal of Health Sciences, 6(S9), 2507–2517. https://doi.org/10.53730/ijhs.v6nS9.12968

Issue

Section

Peer Review Articles